TY - JOUR
T1 - Predictive value of cardiac computed tomography and the impact of renal function on all cause mortality (from coronary computed tomography angiography evaluation for clinical outcomes)
AU - Dwivedi, Girish
AU - Cocker, Myra
AU - Yam, Yeung
AU - Achenbach, Stephan
AU - Al-Mallah, Mouaz
AU - Berman, Daniel S.
AU - Budoff, Matthew J.
AU - Cademartiri, Filippo
AU - Callister, Tracy Q.
AU - Chang, Hyuk Jae
AU - Cheng, Victor
AU - Chinnaiyan, Kavitha M.
AU - Delago, Augustin
AU - Dunning, Allison M.
AU - Hadamitzky, Martin
AU - Hausleiter, Jörg
AU - Kaufmann, Philipp A.
AU - Labounty, Troy M.
AU - Lin, Fay
AU - Maffei, Erica
AU - Raff, Gilbert L.
AU - Shaw, Leslee J.
AU - Villines, Todd C.
AU - Min, James K.
AU - Chow, Benjamin J.W.
N1 - Funding Information:
Dr. Dwivedi is supported by the Dowager Countess Eleanor Peel Trust (Peel and Rothwell Jackson Postgraduate Travelling Fellowship), London, United Kingdom; the Whit & Heather Tucker Endowed Research Fellowship in Cardiology , Ottawa, Ontario, Canada; and the Banting Postdoctoral Fellowship , Ottawa, Ontario, Canada. Dr. Kaufman is supported by the Swiss National Science Foundation , Bern, Switzerland. Dr. Chow is supported by New Investigator Award MSH-83718 from the Canadian Institutes of Health Research , Ottawa, Ontario, Canada.
PY - 2013/6/1
Y1 - 2013/6/1
N2 - Patients with chronic kidney disease have a worse cardiovascular prognosis than those without. The aim of this study was to determine the incremental prognostic value of coronary computed tomographic angiography in predicting mortality across the entire spectrum of renal function in patients with known or suspected coronary artery disease (CAD). A large international multicenter registry was queried, and patients with left ventricular ejection fraction (LVEF) and creatinine data were screened. National Cholesterol Education Program Adult Treatment Panel III risk was calculated. Coronary computed tomographic angiographic results were evaluated for CAD severity (normal, nonobstructive, or obstructive) and an LVEF <50%. Patients were followed for the end point of all-cause mortality. Among 5,655 patients meeting the study criteria, follow-up was available for 5,572 (98.9%; median follow-up duration 18.6 months). All-cause mortality (66 deaths) significantly increased with every 10-unit decrease in renal function (hazard ratio [HR] 1.23, 95% confidence interval [CI] 1.07 to 1.41). All-cause mortality occurred in 0.33% of patients without coronary atherosclerosis, 1.82% of patients with nonobstructive CAD, and 2.43% of patients with obstructive CAD. Multivariate Cox proportional-hazards models revealed that impaired renal function (HR 2.29, 95% CI 1.65 to 3.18), CAD severity (HR 1.81, 95% CI 1.31 to 2.51), and an abnormal LVEF (HR 4.16, 95% CI 2.45 to 7.08) were independent predictors of all-cause mortality. In conclusion, coronary computed tomographic angiographic measures of CAD severity and the LVEF provide effective risk stratification across a wide spectrum of renal function. Furthermore, renal dysfunction, CAD severity, and the LVEF have additive value for predicting all-cause death in patients with suspected obstructive CAD.
AB - Patients with chronic kidney disease have a worse cardiovascular prognosis than those without. The aim of this study was to determine the incremental prognostic value of coronary computed tomographic angiography in predicting mortality across the entire spectrum of renal function in patients with known or suspected coronary artery disease (CAD). A large international multicenter registry was queried, and patients with left ventricular ejection fraction (LVEF) and creatinine data were screened. National Cholesterol Education Program Adult Treatment Panel III risk was calculated. Coronary computed tomographic angiographic results were evaluated for CAD severity (normal, nonobstructive, or obstructive) and an LVEF <50%. Patients were followed for the end point of all-cause mortality. Among 5,655 patients meeting the study criteria, follow-up was available for 5,572 (98.9%; median follow-up duration 18.6 months). All-cause mortality (66 deaths) significantly increased with every 10-unit decrease in renal function (hazard ratio [HR] 1.23, 95% confidence interval [CI] 1.07 to 1.41). All-cause mortality occurred in 0.33% of patients without coronary atherosclerosis, 1.82% of patients with nonobstructive CAD, and 2.43% of patients with obstructive CAD. Multivariate Cox proportional-hazards models revealed that impaired renal function (HR 2.29, 95% CI 1.65 to 3.18), CAD severity (HR 1.81, 95% CI 1.31 to 2.51), and an abnormal LVEF (HR 4.16, 95% CI 2.45 to 7.08) were independent predictors of all-cause mortality. In conclusion, coronary computed tomographic angiographic measures of CAD severity and the LVEF provide effective risk stratification across a wide spectrum of renal function. Furthermore, renal dysfunction, CAD severity, and the LVEF have additive value for predicting all-cause death in patients with suspected obstructive CAD.
UR - http://www.scopus.com/inward/record.url?scp=84877813395&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84877813395&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2013.02.004
DO - 10.1016/j.amjcard.2013.02.004
M3 - Article
C2 - 23499275
AN - SCOPUS:84877813395
VL - 111
SP - 1563
EP - 1569
JO - American Journal of Cardiology
JF - American Journal of Cardiology
SN - 0002-9149
IS - 11
ER -